- Formats
- Injection, troche and oral film
- Injection and troche
- $199 / 4 weeks or $399 / 12 weeks
- Film
- $249 / 4 weeks or $449 / 12 weeks
- Billing
- One-time packages; no automatic renewal advertised
A provider with three distinct formats
GobyMeds publishes individual pages for sermorelin injections, troches and film strips. That gives readers more route-specific documentation than a single generic peptide listing. It does not establish that the three preparations are interchangeable, that every patient can choose freely among them or that a shared ingredient produces the same clinical effect through each route.
The service describes online assessment and a prescription when appropriate, followed by delivery and ongoing provider support. We have not used the consultation service or received these products. This profile focuses on the documented formats, payment terms and questions that remain for the clinician and dispensing pharmacy.
Injection and troche pricing share a structure
Both the injection and troche pages list $199 for a four-week package and $399 for a twelve-week package. The pages use month-based headings, but their stated supply periods are measured in weeks. Keeping those periods visible avoids presenting a four-week supply as though it necessarily covers a full calendar month.
The longer injection and troche offers show a $133 monthly equivalent, consistent with dividing $399 by three. The immediate commitment is still $399. For a reader comparing cash flow, the full payment and the period covered are more informative than the equivalent alone, especially when another provider uses recurring monthly billing.
The film strip has its own prices
The film listing shows $249 for four weeks and $449 for twelve weeks. Its longer-package headline displays $149 per month, while straightforward division gives approximately $149.67 across three stated periods. We retain the full $449 total and explain that arithmetic rather than reproducing a rounded-down headline as an exact amount.
An oral film is also a different dosage form from a troche. GobyMeds describes individually sealed strips and room-temperature storage, whereas the injection requires its own pharmacy handling instructions. Those practical distinctions should be verified against the dispensed label. They do not prove better absorption, outcomes or suitability for travel in all conditions.
What one-time purchase means here
The checked offers say there is no automatic renewal, membership fee or recurring charge. The provider describes one shipment for the selected package, together with clinical access and shipping. Injection supplies are specified on the injectable page. Readers should confirm any testing costs and the exact support available after delivery.
No automatic renewal does not mean no future expense. Another supply may require a new order and clinical review. Ask what happens if the proposed prescription changes after payment, if someone is found ineligible or if a package arrives damaged. A statement about eligibility refunds should not be read as an unrestricted medication-return policy.
Evidence needs to follow the formulation
GobyMeds identifies these preparations as compounded and not FDA-approved. Historical approval of Geref does not extend to the current injectable, troche or film simply because all contain sermorelin. The formulation, route and intended use matter when evaluating any claim about sleep, recovery, body composition or healthy aging.
The provider is worth comparing for its published package totals and variety of documented formats. A clinical preference still requires individualized evaluation and an explanation of the evidence for the actual product. Use the separate product reviews to keep those questions visible, rather than treating the lowest price or a needle-free format as an automatic recommendation.
Useful distinctions
- Each format has its own product page
- Full package totals published
- No membership or automatic renewal advertised
Limitations to weigh
- Week-based supplies differ from calendar months
- Film headline needs arithmetic context
- Routes lack established clinical equivalence
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.